Showing results (71-80 of 1,407) with videos related to
Sort By:
Pageof 141
NPJ Parkinson'S Disease|March 18, 2025
A PheWAS approach to identify associations of GBA1 variants with comprehensive phenotypes beyond neurological diseasesJiaqi Yang, Yuanfeng Huang, Zheng Wang, et al.NPJ Parkinson'S Disease|December 20, 2018
Reduced workforce participation 5 years prior to first Parkinson's disease sick-leaveJonathan Timpka, Örjan Dahlström, Armin Spreco, et al.NPJ Parkinson'S Disease|November 30, 2017
Vertebrate food products as a potential source of prion-like α-synucleinBryan Andrew Killinger, Viviane LabrieNPJ Parkinson'S Disease|February 1, 2019
Basic clinical features do not predict dopamine transporter binding in idiopathic REM behavior disorderL M Chahine, A Iranzo, A Fernández-Arcos, et al.NPJ Parkinson'S Disease|December 17, 2019
Report from a multidisciplinary meeting on anxiety as a non-motor manifestation of Parkinson's diseaseGregory M Pontone, Nadeeka Dissanayka, Liana Apostolova, et al.NPJ Parkinson'S Disease|March 7, 2018
Optimizing Parkinson's disease diagnosis: the role of a dual nuclear imaging algorithmJ William Langston, Jesse C Wiley, Michele TagliatiNPJ Parkinson'S Disease|January 25, 2023
Excessive daytime sleepiness in a model of Parkinson's disease improved by low-frequency stimulation of the pedunculopontine nucleusAurélie Davin, Stéphan Chabardès, Annaelle Devergnas, et al.NPJ Parkinson'S Disease|January 3, 2026
Consensus expert recommendations for referral of Parkinson's disease patients for deep brain stimulation surgeryDelaram Safarpour, Meredith Spindler, Travis H Turner, et al.NPJ Parkinson'S Disease|April 3, 2019
The Parkinson's phenome-traits associated with Parkinson's disease in a broadly phenotyped cohortKarl Heilbron, Alastair J Noyce, Pierre Fontanillas, et al.NPJ Parkinson'S Disease|August 23, 2025
Brain-region-specific lipid dysregulation in L-DOPA-induced dyskinesia in a primate model of Parkinson's diseaseIbrahim Kaya, Theodosia Vallianatou, Anna Nilsson, et al.Pageof 141